Amphotericin B Lipid Complex Amphotericin B
Drug Classes Antifungal Antifungal

FDA Uses

1) Aspergillosis, InUrinary tract mycosis (Severe)Invasive 1) American mucocutaneous leishmaniasis
2) Blastomycosis, Patients who are refractory to or intolerant of conventional amphotericin B 2) Aspergillosis, Invasive
3) Candidal endocarditis 3) Blastomycosis
4) Candidemia 4) Candida endophthalmitis
5) Candidiasis 5) Candidiasis
6) Cryptococcosis 6) Coccidioidomycosis
7) Fungal arthritis, Due to Candida species 7) Cryptococcal meningitis – HIV infection
8) Leishmaniasis, Patients who are refractory to or intolerant of conventional amphotericin B 8) Cryptococcosis
9) Pulmonary aspergillosis, Chronic (cavitary or necrotizing), salvage therapy 9) Fungal infection of central nervous system (Severe)
10) Systemic mycosis, Patients who are refractory to or intolerant of conventional amphotericin B 10) Fungal infection of lung (Severe)
11) Histoplasmosis
12) Histoplasmosis – HIV infection
13) HIV infection – Pulmonary cryptococcosis
14) Infection by Basidiobolus
15) Infection by Conidiobolus
16) Mucormycosis
17) Sporotrichosis
18) Urinary tract mycosis (Severe)
 Administration Intra-articular, Intravenous Intravenous 
Do not confuse Amphotericin B Lipid Complex with Amphotericin B